Loading…
Flutamide Influences Placental Aldo–Keto Reductase Family 1 Member C 1 ( AKR 1 C 1) Expression in Pigs
Aldo–keto reductase family 1 member C 1 ( AKR 1 C 1) catalyses the conversion of progesterone into inactive 20 α ‐dihydroxyprogesterone. It is suggested that AKR 1 C 1 expression in the placenta prevents from the cytotoxic effect of progesterone on foetuses during late pregnancy. The aim of the stud...
Saved in:
Published in: | Reproduction in domestic animals 2014-02, Vol.49 (1) |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aldo–keto reductase family 1 member
C
1 (
AKR
1
C
1) catalyses the conversion of progesterone into inactive 20
α
‐dihydroxyprogesterone. It is suggested that
AKR
1
C
1 expression in the placenta prevents from the cytotoxic effect of progesterone on foetuses during late pregnancy. The aim of the study was to determine whether the anti‐androgen flutamide administered during late pregnancy (83–89 days of gestation) or before parturition (101–107 days of gestation) influences
AKR
1
C
1 expression in the porcine placenta.
AKR
1
C
1
mRNA
and protein levels were measured using real‐time
PCR
and western blotting, respectively. Immunolocalization of
AKR
1
C
1 within placentas was also performed. Flutamide significantly increased
AKR
1
C
1
mRNA
(p = 0.008) and protein (p = 0.019) expression only during the pre‐parturient period in pigs.
AKR
1
C
1 protein was immunolocalized in the epithelial and stromal cells of foetal and maternal part of placenta at both stages of gestation. Following flutamide treatment, the intensity of staining was higher (p = 0.045) on day 108 of gestation. In conclusion, porcine placental
AKR
1
C
1 expression seems to be regulated by an androgen signalling pathway and may be involved in foetal survival by preventing the detrimental effect of progesterone. |
---|---|
ISSN: | 0936-6768 1439-0531 |
DOI: | 10.1111/rda.12263 |